12:00 AM
 | 
May 26, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Status

OMS201: Phase I started

Omeros began a double-blind, placebo-controlled, U.S. Phase I trial to evaluate OMS201 in at least 24 patients undergoing...

Read the full 68 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >